{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:53:55Z","timestamp":1794920035478,"version":"4.9.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1681\/asn.2013030251","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T23:07:44Z","timestamp":1391123264000},"page":"850-863","source":"Crossref","is-referenced-by-count":243,"title":["Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome"],"prefix":"10.1681","volume":"25","author":[{"given":"Piero","family":"Ruggenenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cravedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vivarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Massella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Maras\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Chianca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Rubis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Ene-Iordache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rudnicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Pollastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pennesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Emma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-25-20230208","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(10)60236-X","article-title":"Genetic kidney diseases.","volume":"375","author":"Hildebrandt","year":"2010","journal-title":"Lancet"},{"key":"R3-25-20230208","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00467-011-1947-1","article-title":"Physiopathology of idiopathic nephrotic syndrome: Lessons from glucocorticoids and epigenetic perspectives.","volume":"27","author":"Elie","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R4-25-20230208","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","article-title":"Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children.","volume":"8","author":"Tarshish","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R5-25-20230208","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: Clinical characteristics, treatment, and outcomes.","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R6-25-20230208","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1523-1755.1999.07002.x","article-title":"Management of minimal lesion glomerulonephritis: Evidence-based recommendations.","volume":"70","author":"Bargman","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"R7-25-20230208","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00467-004-1434-z","article-title":"Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy.","volume":"19","author":"Benz","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R8-25-20230208","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00467-010-1465-6","article-title":"Rituximab efficiency in children with steroid-dependent nephrotic syndrome.","volume":"25","author":"Sellier-Leclerc","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R9-25-20230208","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","article-title":"Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.","volume":"27","author":"Kemper","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R10-25-20230208","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.2012.444","article-title":"Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease.","volume":"83","author":"Munyentwali","year":"2013","journal-title":"Kidney Int"},{"key":"R11-25-20230208","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-009-1377-5","article-title":"Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.","volume":"25","author":"Fujinaga","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R12-25-20230208","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: A randomized controlled trial.","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R13-25-20230208","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","article-title":"Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children.","volume":"24","author":"Kamei","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R14-25-20230208","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/ndt\/gfs515","article-title":"Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults.","volume":"28","author":"Takei","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R15-25-20230208","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program.","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"R16-25-20230208","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2215\/CJN.01180307","article-title":"Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy.","volume":"2","author":"Cravedi","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-25-20230208","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","article-title":"Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.","volume":"51","author":"Tanner","year":"1976","journal-title":"Arch Dis Child"},{"key":"R18-25-20230208","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1055\/s-2006-944530","article-title":"Cortisol resistance in conditions such as asthma and the involvement of 11beta-HSD-2: A hypothesis.","volume":"38","author":"Pretorius","year":"2006","journal-title":"Horm Metab Res"},{"key":"R19-25-20230208","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00467-003-1176-3","article-title":"Long-term linear growth of children with severe steroid-responsive nephrotic syndrome.","volume":"18","author":"Emma","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"R20-25-20230208","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ndt\/gfr220","article-title":"Idiopathic membranous nephropathy and nephrotic syndrome: Outcome in the era of evidence-based therapy.","volume":"27","author":"McQuarrie","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R21-25-20230208","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJM199510053331409","article-title":"Clinical problem solving. The girl with the curl.","volume":"333","author":"Remuzzi","year":"1995","journal-title":"N Engl J Med"},{"key":"R22-25-20230208","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ndt\/14.suppl_3.68","article-title":"Clinical picture and outcome of primary focal segmental glomerulosclerosis.","volume":"14","author":"Korbet","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"R23-25-20230208","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.2011080775","article-title":"Rituximab in children with resistant idiopathic nephrotic syndrome.","volume":"23","author":"Magnasco","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R24-25-20230208","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.","volume":"84","author":"Ravani","year":"2013","journal-title":"Kidney Int"},{"key":"R25-25-20230208","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199604043341402","article-title":"Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.","volume":"334","author":"Savin","year":"1996","journal-title":"N Engl J Med"},{"key":"R26-25-20230208","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.ajkd.2006.10.015","article-title":"Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: First case report and pathophysiological considerations.","volume":"49","author":"Fran\u00e7ois","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R27-25-20230208","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2005.05.004","article-title":"Focal and segmental glomerulosclerosis and plasma cell proliferative disorders.","volume":"46","author":"Dingli","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R28-25-20230208","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R29-25-20230208","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/CS20040095","article-title":"Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome.","volume":"107","author":"van den Berg","year":"2004","journal-title":"Clin Sci (Lond"},{"key":"R30-25-20230208","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"R31-25-20230208","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/14740330902750114","article-title":"Ten years of rituximab in NHL.","volume":"8","author":"Winter","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"R32-25-20230208","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3949\/ccjm.78.s2.04","article-title":"Pharmacovigilance and PML in the oncology setting.","volume":"78","author":"Bennett","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"R33-25-20230208","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1681\/ASN.V92310","article-title":"Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease.","volume":"9","author":"Gaspari","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R34-25-20230208","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0022-3476(88)80570-5","article-title":"Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: Superiority of response to corticosteroid therapy over histopathologic patterns.","volume":"113","author":"Schulman","year":"1988","journal-title":"J Pediatr"},{"key":"R35-25-20230208","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ije\/28.5.964","article-title":"The use of fractional polynomials to model continuous risk variables in epidemiology.","volume":"28","author":"Royston","year":"1999","journal-title":"Int J Epidemiol"},{"key":"R36-25-20230208","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R37-25-20230208","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201404000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:23:47Z","timestamp":1786130627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201404000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013030251","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}